Low-abundance exosomal proteins from trace plasma volumes remain challenging to profile by mass spectrometry. Here, we report a lanthanide metal-organic framework (Ln-MOF) functionalized with boronic acid and carboxylate dual ligands, which captures exosomal proteins via synergistic phosphate coordination, boronate-diol complexation, and cation-π interactions. Compared with traditional ultracentrifugation, which identifies 1003 proteins from 200 µL of plasma, the Ln-MOF method identifies 1523 proteins from only 50 µL of plasma. Notably, the method enriches glycoproteins and phosphoproteins by 2.1-fold and 1.8-fold, respectively. Applying this platform to pancreatic ductal adenocarcinoma (PDAC) patients and healthy controls, we delineate tumor tissue hypermetabolism vs. systemic immune suppression.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: